Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2025
Filed with the SEC on Aug 29, 2025 and accepted by EDGAR at Aug 29, 2025, 16:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-05-01 to 2025-07-31 | $1.74bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-11-01 to 2025-07-31 | $5.09bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-05-01 to 2025-07-31 | $850.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-11-01 to 2025-07-31 | $2.43bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2025-05-01 to 2025-07-31 | $111.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-11-01 to 2025-07-31 | $336.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-05-01 to 2025-07-31 | $417.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-11-01 to 2025-07-31 | $1.28bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-05-01 to 2025-07-31 | $360.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-11-01 to 2025-07-31 | $1.04bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-05-01 to 2025-07-31 | $28.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2024-11-01 to 2025-07-31 | $85.0m | us-gaap:InterestExpense |
| Income tax | 3 months2025-05-01 to 2025-07-31 | $30.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-11-01 to 2025-07-31 | $124.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-05-01 to 2025-07-31 | $336.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-11-01 to 2025-07-31 | $869.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-05-01 to 2025-07-31 | $1.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-11-01 to 2025-07-31 | $3.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-05-01 to 2025-07-31 | $1.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-11-01 to 2025-07-31 | $3.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-05-01 to 2025-07-31 | 285,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-11-01 to 2025-07-31 | 285,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-11-01 to 2025-07-31 | $1.01bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-11-01 to 2025-07-31 | $314.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2025-05-01 to 2025-07-31 | $71.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2024-11-01 to 2025-07-31 | $212.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2024-11-01 to 2025-07-31 | $340.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-07-31 | $1.53bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-07-31 | $4.25bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-07-31 | $12.23bn | us-gaap:Assets |
| Current liabilities | At period end2025-07-31 | $1.89bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-07-31 | $5.86bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-07-31 | $3.35bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2025-07-31 | $59.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-07-31 | $6.37bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-25-000036. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.